Encompass Health price to free cash flow EHC

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026: 29.6×
10-year median: 22.7×
Against its 10-year history: 75th; percentile: 0 is its lowest day, 100 its highest
10-year range: 6.3× to 69.8×
Peer median: 19.7×

Encompass Health's price to free cash flow is 29.6× as of Oct 23, 2026.

That is above its ten-year median of 22.7×, higher than on 75% of days in the last ten years.

Over that time it ranged from 6.3× in Jan 2017 to 69.8× in Feb 2023.

The median for 10 hospital and care facility stocks of a similar size is 19.7×.

Price to free cash flow over time

median 22.7×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	29.6×	20.9×	30.5×
2025	26.9×	26.6×	39.3×
2024	36.5×	25.1×	47.3×
2023	24.6×	23.2×	69.8×
2022	66.4×	12.0×	66.4×
2021	13.1×	11.7×	25.4×
2020	24.0×	15.0×	47.8×
2019	21.4×	9.0×	22.1×
2018	9.8×	9.8×	13.5×
2017	9.6×	6.3×	9.7×
2016	6.6×	6.3×	8.2×
2015	8.0×	7.7×	11.9×
2014	8.9×	7.6×	11.1×
2013	8.2×	5.9×	8.8×
2012	5.6×	5.6×	8.3×
2011	7.1×	4.6×	8.0×

Against its peers

Companies in Medical - Care Facilities nearest Encompass Health's size, closest first, today.

Company	Price to free cash flow
EHCEncompass Health	29.6×
BTSGBrightSpring Health Services	29.6×
DVADavita	7.3×
UHSUniversal Health Services	13.0×
ENSGEnsign	24.4×
PACSPACS	16.6×
THCTenet Healthcare	7.2×
CHEChemed	20.7×
SHCSotera Health	45.8×
CONConcentra Group Holdings Parent	18.7×
LFSTLifeStance Health	28.4×
Peer median	19.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Encompass Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.